Skip to main content
. Author manuscript; available in PMC: 2023 Mar 22.
Published in final edited form as: N Engl J Med. 2022 Sep 22;387(12):1075–1088. doi: 10.1056/NEJMoa2200436

Figure 1. Cumulative Incidences of Hypertension and Dyslipidemia in the Intention-to-Treat Analyses.

Figure 1.

Shown are the cumulative incidences of hypertension (Panel A) and dyslipidemia (Panel B) over 6.5 years of follow-up among participants who did not have each condition at baseline. The numbers plotted below the x axis of each panel are the numbers of participants at risk for the outcome at each follow-up time point (i.e., the number of participants in whom a specified outcome event had not developed by that time). Participants who had the condition at baseline were excluded, leaving 1168 of 5047 participants (23%) in the analysis of hypertension and 195 of 5047 participants (4%) in the analysis of dyslipidemia. There was no substantial difference among the groups with respect to the cumulative incidences of hypertension or dyslipidemia.